Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NIH licensing a class of gp100 cancer antigens

March 26, 2003

GTI-2040 awarded orphan drug status for renal cell cancer

March 26, 2003

Methods of prophylaxis and treatment of HER-2/neu tumors

March 25, 2003

Novel GnRH antagonists discovered by Neurocrine scientists

March 25, 2003

Pharma Mar identifies new antitumor ecteinascidin derivatives

March 25, 2003

Combination therapy containing zosuquidar reverses multidrug resistance in AML

March 25, 2003

Long-lasting antitumor activity reported for Bexxar in refractory B-cell lymphoma

March 25, 2003

Photofrin approved in Canada for HGD associated with Barrett's esophagus

March 24, 2003

CV Therapeutics identifies adenosine A3 receptor agonists with utility in cancer and neutropenia

March 24, 2003

Promising preclinical findings for aplidine in leukemia and lymphoma

March 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...